Search

everythinglearnresearchcommunity

for

Search:↓

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Bidirectional barbed sutures are effective and can reduce surgery time, with a low infection rate and potential cost savings despite being more expensive.

Surgeons suggested a standard system for hair transplant methods to improve communication and results.

COVID-19 infection may trigger alopecia areata in some patients.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Photodynamic Therapy is an effective treatment for mild to severe acne.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

Hair follicle transplantation can hide scars but often needs more than one surgery for better results.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.